Today’s Solutions: December 20, 2025

The pandemic has taken a toll on African start-ups. One estimate predicts that investment in African startups could drop by as much as 40 percent by the end of the year. In an effort to keep these companies afloat, Ventures Platform, an Abuja, Nigeria-based early-stage fund, is creating a relief program to provide emergency grants to keep innovation alive. 

The equity-free grants can be up to $20,000 and will be available to early, high-growth stage startups in need of cash lifelines. The funds are being procured in partnership with Acumen, a New York-based impact investor, and LoftyInc, a Lagos-based investment firm.  

During the pandemic, investors have become more risk-averse and young companies tend to be hit hardest by financial recessions. To qualify for a grant, startups must have raised seed capital and have accrued annual revenues of $60,000 before the pandemic struck.

The demand for these grants is high. According to the Ventures Platform, the program is already reviewing 2,700 applications. Perhaps this program will offer a lifeline to one of the world’s most innovative companies of the future.

Solutions News Source Print this article
More of Today's Solutions

Try this simple breathing exercise to rid yourself of cold hands and feet

Do you often find that your hands and feet are colder than the rest of your body? This can be perplexing, especially when gloves ...

Read More

Roman jars reveal the secrets of ancient winemaking

Archaeologists are still putting the full story of human history together. From the discovery of a Viking shipyard in Sweden to the Sistine Chapel ...

Read More

Cancer detection breakthrough revealed via butterfly-inspired imaging

In the world of sensory perception, other creatures frequently outperform humans. A research team has created an imaging sensor that looks into the elusive ultraviolet ...

Read More

Advancements in vision restoration: CRISPR gives hope to patients 

In a revolutionary development, CRISPR gene editing emerged as a beacon of hope for people suffering from genetic blindness. The results of a Phase ...

Read More